Erytech Pharma S.A. (ERYP): Price and Financial Metrics
ERYP Price/Volume Stats
| Current price | $0.78 | 52-week high | $1.47 |
| Prev. close | $0.78 | 52-week low | $0.30 |
| Day low | $0.78 | Volume | 3,200 |
| Day high | $0.88 | Avg. volume | 93,510 |
| 50-day MA | $0.88 | Dividend yield | N/A |
| 200-day MA | $0.74 | Market Cap | 26.61M |
ERYP Stock Price Chart Interactive Chart >
Erytech Pharma S.A. (ERYP) Company Bio
ERYTECH Pharma Société Anonyme, a clinical-stage biopharmaceutical company, develops therapies for rare forms of cancer and orphan diseases in France and internationally. The company is developing a pipeline of product candidates targeting markets with unmet medical need using its proprietary ERYCAPS platform, a technology to encapsulate therapeutic drug substances inside red blood cells. It primarily focuses on the treatment of blood cancers, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), by depriving tumors of nutrients necessary for their survival. The company was founded in 2004 and is based in Lyon, France.
ERYP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -85.95% |
| 2021 | -74.54% |
| 2020 | 25.15% |
| 2019 | 8.94% |
Continue Researching ERYP
Want to see what other sources are saying about Erytech Pharma SA's financials and stock price? Try the links below:Erytech Pharma SA (ERYP) Stock Price | Nasdaq
Erytech Pharma SA (ERYP) Stock Quote, History and News - Yahoo Finance
Erytech Pharma SA (ERYP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...